Slideshow
Author(s):
These apps are designed to improve treatment adherence, language skills, symptom tracking, communication, and other helpful functions.
FDA Action Update, February 2025: Approvals, Designations, and Acceptances
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
FDA Closes Inspection of Site for Phase 3 TRANQUILITY II Trial of BXCL501 in Alzheimer Agitation
Neurology Unwrapped: 2024’s Most Intriguing Conversations
NeurologyLive® Brain Games: March 2, 2025
This Week on NeurologyLive® — February 24, 2025